- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02737540
Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients (SPAD)
Visão geral do estudo
Status
Condições
Descrição detalhada
The secondary objectives are to confirm or explore the deficits of certain cognitive processes involved in potentially suicidal behavior in depressed elderly persons but that have been little or not studied to date. These include:
A. cognitive control and sensitivity to interference (Victoria Stroop test, incompatibility test, flexibility test, Go / No-Go);
B. Strategic recovery of semantic memory (verbal fluency test);
C. Working memory (TEA);
D. Insight related to depression (Mood Disorders Insight Scale);
E. Recognition of facial emotions;
F. Emotional regulation;
G. Negative attitudes;
H. Self-perception and;
I. Time perspectives.
Finally, patients will be contacted by telephone at month 6 to assess the occurrence of a suicidal act during this period and thus calculate the predictive ability of cognitive and psychological factors.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Nîmes, França, 30000
- Clinique Les Sophoras
-
Nîmes Cedex 09, França, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion criteria for patients:
- The patient or his/her representative must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- Patients with a diagnosis of current, moderate to severe, major depressive episode according to the DSM diagnostic criteria 5. This episode can be considered as part of a major depressive disorder or bipolar disorder.
- Patients with or without a personal history of suicide attempts. A suicide attempt is defined as any act performed with some intent to die (Mann 1998). Suicidal threats, aborted or interrupted gestures as well as self-mutilating acts without suicidal intent will not be considered as suicidal acts.
- Patients hospitalized (or followed as outpatients) in the Nîmes University Hospital psychiatry department or the Sophoras clinic in Nimes
Inclusion criteria for healthy subjects:
- The subject or his/her representative must have given his/her informed and signed consent
- The subject must be insured or beneficiary of a health insurance plan
- Non-depressed subject without personal history of lifetime mood disorder or severe mental illness, or substance or alcohol abuse during the past 12 months
Exclusion criteria for patients:
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection
- The patient (or his/her legal representative) refuses to sign the consent
- It is impossible to correctly inform the patient or his/her legal representative
- The patient has a known MMSE score <24 (elimination of probable dementia pathology)
- Known central neurological disease including degenerative disease, severe head trauma and severe cerebral vascular disease
- Known schizophrenia and other psychotic disorders
- Alcohol or substance abuse in the last 12 months
- Electroconvulsive therapy in the 12 months preceding the study because of the risk of mnesic side effects
- Inability to perform neuropsychological tests because of a language problem, poor understanding, a major tremor, inability to sit still, a major sight problem that can not be corrected, or other severe cognitive impairment
- The subject presents an acute somatic decompensation incompatible with the completion of this study
- The patient has current confusion
Exclusion criteria for healthy subjects:
- The subject is participating in another study
- The subject is in an exclusion period determined by a previous study
- The subject is under judicial protection
- The subject (or his/her legal representative) refuses to sign the consent
- It is impossible to correctly inform the subject or his/her legal representative
- The subject has a known MMSE score <24 (elimination of probable dementia pathology)
- Known central neurological disease including degenerative disease, severe head trauma and severe cerebral vascular disease
- Known schizophrenia and other psychotic disorders
- Alcohol or substance abuse in the last 12 months
- Electroconvulsive therapy in the 12 months preceding the study because of the risk of mnesic side effects
- Inability to perform neuropsychological tests because of a language problem, poor understanding, a major tremor, inability to sit still, a major sight problem that can not be corrected, or other severe cognitive impairment
- The subject has a mood disorder
- The subject presents an acute somatic decompensation incompatible with the completion of this study
- Thesubject has current confusion
Pharmacological treatment is not a criterion for exclusion in itself but it will be left to the judgment of the evaluator to choose to include a subject or not (or to postpone inclusion) depending on the drug (eg. after weaning daytime sedative treatment and benzodiazepines).
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
---|
Major depressive episode
This study population consists of patients over 60 years of age with or without a personal history of suicide attempts, hospitalized in the Nîmes University Hospital psychiatry department or the Sophoras clinic for a major depressive episode.
|
Healthy subjects
Healthy subjects over 60 years, not depressed and without personal history of severe mental illness or suicide attempts will be recruited.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
---|---|
Trust Game
Prazo: Days 1-7
|
Days 1-7
|
Ultimatum Game
Prazo: Days 1-7
|
Days 1-7
|
Iowa Gambling Task
Prazo: Days 1-7
|
Days 1-7
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
---|---|
Stroop Victoria Test
Prazo: Days 1-7
|
Days 1-7
|
Incompatibility Test
Prazo: Days 1-7
|
Days 1-7
|
Flexibility test
Prazo: Days 1-7
|
Days 1-7
|
Go-NoGo
Prazo: Days 1-7
|
Days 1-7
|
Working memory - TEA
Prazo: Days 1-7
|
Days 1-7
|
Mood Disorders Insight Scale
Prazo: Days 1-7
|
Days 1-7
|
Verbal fluency test
Prazo: Days 1-7
|
Days 1-7
|
Future autobiographical fluency task
Prazo: Days 1-7
|
Days 1-7
|
Bristol Emotion Recognition Test
Prazo: Days 1-7
|
Days 1-7
|
Cognitive Emotion Regulation Questionnaire
Prazo: Days 1-7
|
Days 1-7
|
Questionnaire on negative attitudes towards problems
Prazo: Days 1-7
|
Days 1-7
|
Revised self-awareness scale, Self-reference task
Prazo: Days 1-7
|
Days 1-7
|
Balanced Temporal Perspective Scale
Prazo: Days 1-7
|
Days 1-7
|
Suicide attempt within 6 months of follow-up
Prazo: Month 6
|
Month 6
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Fabrice JOLLANT, MD, Centre Hospitalier Universitaire de Nimes
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- LOCAL/2016/MW-01
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Transtorno Depressivo Maior
-
Centre Hospitalier Universitaire de Saint EtienneBayerRescindido
-
Memorial Sloan Kettering Cancer CenterAtivo, não recrutandoDiagnóstico confirmado de ß-talassemia MajorEstados Unidos
-
Assiut UniversityAinda não está recrutando
-
Università degli Studi di FerraraConcluído
-
HaEmek Medical Center, IsraelConcluído
-
Cerus CorporationConcluído
-
National Taiwan University HospitalRecrutamentoTalassemia MajorTaiwan
-
DisperSol Technologies, LLCConcluídoTalassemia MajorTailândia, Estados Unidos
-
Assiut UniversityConcluído
-
National Human Genome Research Institute (NHGRI)ConcluídoTalassemia MajorCingapura